Primo Nutraceuticals Inc.

OTCPK:BUGV.F Stock Report

Market Cap: US$25.0

Primo Nutraceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Richard Cindric

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.5yrs
CEO ownershipn/a
Management average tenure4.5yrs
Board average tenureno data

Recent management updates

No updates

Recent updates

No updates

CEO

Richard Cindric

4.5yrs

Tenure

Mr. Richard Cindric serves as Chief Executive Officer at Primo Nutraceuticals Inc. (formerly known as Bougainville Ventures Inc.) since July 7, 2020 and serves as its Director. Mr. Cindric has extensive ex...

Leadership Team

NamePositionTenureCompensationOwnership
Richard Cindric
CEO & Director4.5yrsno datano data
Amandip Jagpal
President & Directorno datano datano data
Teja Singh
CFO & Director4.5yrsno datano data
Bal Bhullar
Vice President of Legal Affairs & Corporate Development5yrsno datano data
Andy Dhaliwal
Vice President of Sales and Distribution5.3yrsno datano data
Mark Bechtel
Corporate Secretary4.5yrsno datano data

4.5yrs

Average Tenure

Experienced Management: BUGV.F's management team is considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:14
End of Day Share Price 2024/12/17 00:00
Earnings2020/04/30
Annual Earnings2019/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Primo Nutraceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution